Montgomery & Ponder, LLC is currently investigating claims for damages related to compulsive behavior, such as excessive gambling, for people who have taken Rexulti.
The label on Rexulti carries “Black Box” warning labels about the risk of increased suicidal thoughts and behaviors for teenagers and young adults who are on antidepressants. On February 15, 2018, the FDA updated the Rexulti label to include the following information:
"Post-marketing case reports suggest that patients can experience intense urges, particularly for gambling, and the inability to control these urges while taking REXULTI. Other compulsive urges, reported less frequently, include: sexual urges, shopping, eating or binge eating, and other impulsive or compulsive behaviors. Because patients may not recognize these behaviors as abnormal, it is important for prescribers to ask patients or their caregivers specifically about the development of new or intense gambling urges, compulsive sexual urges, compulsive shopping, binge or compulsive eating, or other urges while being treated with REXULTI. In some cases, although not all, urges were reported to have stopped when the dose was reduced or the medication was discontinued. Compulsive behaviors may result in harm to the patient and others if not recognized. Consider dose reduction or stopping the medication if a patient develops such urges."
Rexulti is approved for the treatment of adults with schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Rexulti is also approved as an add-on treatment to antidepressants for the treatment of adults with major depressive disorder (MDD).
You may be eligible to file a claim if you:
- No longer use REXULTI.
- Developed a gambling problem after beginning treatment with REXULTI;
- Have no prior history of compulsive gambling;
- Suffered gambling losses of more than $50,000; and
- Have documentation to prove your losses: ATM receipts from the casino, bank statements, or a player’s card summary given to you at the facility.
If you or a loved one has suffered the above-described behaviors following the use of Rexulti, please contact our firm immediately at (205) 377-5004.